News | May 03, 2023
Astec LifeSciences FY23 PAT declines to Rs. 25.6 Cr
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
The business and product range of Ipca and that of Unichem complements each others business and product range
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
The Theme of the event was 'Building One Health Together – Improving Health Equity'
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
To enable company to be future-ready by tapping potential in CDMO space
Subscribe To Our Newsletter & Stay Updated
